• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53的腺病毒表达通过下调人端粒酶逆转录酶转录来抑制端粒酶活性。

Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.

作者信息

Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, Inoue M

机构信息

Department of Obstetrics and Gynecology, School of Medicine, Kanazawa University, Ishikawa, Japan.

出版信息

Clin Cancer Res. 2000 Apr;6(4):1239-47.

PMID:10778946
Abstract

Telomerase activation is a critical step in cellular immortality and oncogenesis. The activity of telomerase is known to be correlated with cell proliferation, but its regulation by cell cycle regulators is not well understood. In the present study, we examined the effects of p53 on telomerase activity. Wild-type p53 was introduced into SiHa cells via a recombinant adenoviral vector, Ad5CMV-p53, and change in telomerase activity was examined by quantitative telomerase assay. Telomerase activity in the Ad5CMV-p53-infected cells was significantly repressed 36 h after infection following down-regulation of human telomerase catalytic subunit [human telomerase reverse transcriptase (hTERT)] mRNA expression, whereas no change in telomerase activity was observed in the cells infected with control vector AdSCMV-beta-gal. Interestingly, repression of telomerase activity was an early event that preceded cell growth inhibition or apoptosis induced by p53 overexpression, suggesting that p53 directly regulates telomerase activity. Transient expression assays using hTERT-promoter reporter constructs revealed that overexpression of p53 significantly repressed promoter activity of hTERT. 5'-Truncation of the promoter sequences revealed that the proximal core promoter region containing multiple binding sites for transcription factor Spl was responsible for p53-mediated transcriptional repression. Mutations in these binding sites for Spl led to failure of p53 to repress transcription. These findings suggest that p53 repressed telomerase activity through down-regulation of hTERT transcription and that interaction of p53 with Sp1 or other transcription factors may be involved in this regulation.

摘要

端粒酶激活是细胞永生化和肿瘤发生的关键步骤。已知端粒酶活性与细胞增殖相关,但其受细胞周期调节因子的调控机制尚不清楚。在本研究中,我们检测了p53对端粒酶活性的影响。通过重组腺病毒载体Ad5CMV-p53将野生型p53导入SiHa细胞,并通过定量端粒酶检测法检测端粒酶活性的变化。Ad5CMV-p53感染的细胞在感染后36小时,随着人端粒酶催化亚基[人端粒酶逆转录酶(hTERT)]mRNA表达的下调,端粒酶活性显著受到抑制,而感染对照载体AdSCMV-β-gal的细胞中端粒酶活性未观察到变化。有趣的是,端粒酶活性的抑制是p53过表达诱导的细胞生长抑制或凋亡之前的早期事件,这表明p53直接调节端粒酶活性。使用hTERT启动子报告构建体的瞬时表达分析表明,p53的过表达显著抑制了hTERT的启动子活性。启动子序列的5'端截短显示,包含转录因子Spl多个结合位点的近端核心启动子区域负责p53介导的转录抑制。这些Spl结合位点的突变导致p53无法抑制转录。这些发现表明,p53通过下调hTERT转录来抑制端粒酶活性,并且p53与Sp1或其他转录因子的相互作用可能参与了这种调控。

相似文献

1
Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.p53的腺病毒表达通过下调人端粒酶逆转录酶转录来抑制端粒酶活性。
Clin Cancer Res. 2000 Apr;6(4):1239-47.
2
Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.野生型p53对人肿瘤细胞中端粒酶逆转录酶mRNA表达的下调作用。
Oncogene. 2000 Oct 26;19(45):5123-33. doi: 10.1038/sj.onc.1203890.
3
Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.p16INK4a的导入通过转录抑制人胶质瘤中人类端粒酶逆转录酶的表达来抑制端粒酶活性。
Int J Oncol. 2004 May;24(5):1213-20.
4
Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.正常与恶性人卵巢上皮细胞中人类端粒酶逆转录酶启动子调控
Cancer Res. 2001 Jul 15;61(14):5529-36.
5
Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1.hTERT基因的表达在转录起始水平受到调控,并被Mad1抑制。
Cancer Res. 2000 Apr 15;60(8):2116-21.
6
Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT.去甲基化试剂5-氮杂胞苷通过转录抑制人端粒酶逆转录酶(hTERT)来抑制人前列腺癌细胞中的端粒酶活性。
Clin Cancer Res. 2000 Jul;6(7):2868-75.
7
Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.金雀异黄素通过转录和翻译后机制抑制人前列腺癌细胞中的端粒酶活性。
Cancer Res. 2006 Feb 15;66(4):2107-15. doi: 10.1158/0008-5472.CAN-05-2494.
8
Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.hTERT表达的下调在15-脱氧-Δ12,14-前列腺素J2诱导的癌细胞凋亡中起重要作用。
Int J Oncol. 2009 May;34(5):1363-72.
9
Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.人端粒酶催化亚基(hTERT)基因启动子的克隆以及对永生化细胞和癌细胞中转录激活所必需的近端核心启动子序列的鉴定。
Cancer Res. 1999 Feb 1;59(3):551-7.
10
Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.腺病毒介导的p53基因转导抑制人胰腺癌细胞中的端粒酶活性,且该作用独立于其对细胞周期阻滞和细胞凋亡的影响。
Clin Cancer Res. 1999 Aug;5(8):2140-7.

引用本文的文献

1
EZH2 inhibition and 5-azacytidine enhance antitumor immunity in PTEN-deficient glioblastoma by activation viral mimicry response.EZH2抑制和5-氮杂胞苷通过激活病毒模拟反应增强PTEN缺陷型胶质母细胞瘤的抗肿瘤免疫力。
J Immunother Cancer. 2025 Jun 13;13(6):e011650. doi: 10.1136/jitc-2025-011650.
2
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.端粒、端粒酶与癌症:作用机制、生物标志物及治疗方法
Exp Hematol Oncol. 2025 Jan 27;14(1):8. doi: 10.1186/s40164-025-00597-9.
3
Impact of khat (Catha edulis) and oral contraceptive use on telomerase levels and tumor suppressor genes p53 and p21 in normal subjects and breast cancer patients.
阿拉伯茶(巧茶)和口服避孕药对正常人群和乳腺癌患者端粒酶水平及抑癌基因 p53 和 p21 的影响。
Sci Rep. 2024 Jul 16;14(1):16365. doi: 10.1038/s41598-024-67355-5.
4
Obesity: a perfect storm for carcinogenesis.肥胖:致癌作用的完美风暴。
Cancer Metastasis Rev. 2022 Sep;41(3):491-515. doi: 10.1007/s10555-022-10046-2. Epub 2022 Aug 30.
5
Telomerase in Cancer: Function, Regulation, and Clinical Translation.癌症中的端粒酶:功能、调控及临床转化
Cancers (Basel). 2022 Feb 5;14(3):808. doi: 10.3390/cancers14030808.
6
Mechanism of Human Telomerase Reverse Transcriptase () Regulation and Clinical Impacts in Leukemia.人类端粒酶逆转录酶()的调节机制及其在白血病中的临床影响。
Genes (Basel). 2021 Jul 30;12(8):1188. doi: 10.3390/genes12081188.
7
Prognostic Alternative Splicing Signatures in Esophageal Carcinoma.食管癌中的预后性可变剪接特征
Cancer Manag Res. 2021 Jun 4;13:4509-4527. doi: 10.2147/CMAR.S305464. eCollection 2021.
8
Telomerase Regulation: A Role for Epigenetics.端粒酶调控:表观遗传学的作用
Cancers (Basel). 2021 Mar 10;13(6):1213. doi: 10.3390/cancers13061213.
9
Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate.端粒长度在小细胞神经内分泌前列腺癌和前列腺腺癌之间有显著差异。
Hum Pathol. 2020 Jul;101:70-79. doi: 10.1016/j.humpath.2020.04.014. Epub 2020 May 7.
10
Analysis of Telomere Lengths in p53 Signatures and Incidental Serous Tubal Intraepithelial Carcinomas Without Concurrent Ovarian Cancer.p53 特征中端粒长度分析与无伴发卵巢癌的偶然浆液性输卵管上皮内癌。
Am J Surg Pathol. 2019 Aug;43(8):1083-1091. doi: 10.1097/PAS.0000000000001283.